Breaking News Instant updates and real-time market news.

PB

Prosperity Bancshares

$65.35

-0.18 (-0.27%)

, CRVS

Corvus Pharmaceuticals

$11.84

-0.25 (-2.07%)

10:33
08/03/17
08/03
10:33
08/03/17
10:33

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Prosperity Bancshares (PB) initiated with an Overweight at Barclays. 2. Corvus Pharmaceuticals (CRVS) initiated with an Outperform at Wedbush. 3. Molecular Templates (MTEM) initiated with a Buy at Ladenburg. 4. PVH Corp. (PVH) reinstated with a Buy at BofA/Merrill. 5. Esquire Financial (ESQ) initiated with a Buy at Sandler O'Neill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

PB

Prosperity Bancshares

$65.35

-0.18 (-0.27%)

CRVS

Corvus Pharmaceuticals

$11.84

-0.25 (-2.07%)

MTEM

Molecular Templates

$5.50

4.96 (918.52%)

PVH

PVH Corp.

$120.51

0.78 (0.65%)

ESQ

Esquire Financial

$14.80

-0.09 (-0.60%)

  • 18

    Sep

PB Prosperity Bancshares
$65.35

-0.18 (-0.27%)

08/03/17
LEHM
08/03/17
INITIATION
Target $72
LEHM
Overweight
Prosperity Bancshares initiated with an Overweight at Barclays
Barclays analyst Matthew Keating started Prosperity Bancshares with an Overweight rating and $72 price target. The analyst sees the company benefiting from accelerating organic loan growth accelerating and a recovering Texas economy.
06/05/17
MSCO
06/05/17
NO CHANGE
MSCO
Midcap Bank sector upgraded to In-Line at Morgan Stanley
Morgan Stanley analyst Ken Zerbe upgraded the Midcap Bank sector to In-Line from Cautious citing the group's underperformance year-to-date and better earnings from lower deposit betas. The firm's top picks are SVB Financial (SIVB), Signature Bank (SBNY), KeyBanc (KEY), and Citizens Financial (CFG). Note the analyst upgraded People's United (PBCT) and Prosperity Bancshares (PB) to Equal Weight citing valuations.
06/05/17
MSCO
06/05/17
UPGRADE
MSCO
Equal Weight
Prosperity Bancshares upgraded to Equal Weight on valuation at Morgan Stanley
As previously reported, Morgan Stanley upgraded Prosperity Bancshares to Equal Weight from Underweight. Analyst Ken Zerbe changed his view citing balanced risk/reward following a period of underperformance year-to-date.
06/05/17
MSCO
06/05/17
UPGRADE
MSCO
Equal Weight
Prosperity Bancshares upgraded to Equal Weight from Underweight at Morgan Stanley
CRVS Corvus Pharmaceuticals
$11.84

-0.25 (-2.07%)

05/01/17
FBCO
05/01/17
DOWNGRADE
Target $10
FBCO
Underperform
Corvus Pharmaceuticals downgraded to Underperform at Credit Suisse
Credit Suisse downgraded Corvus Pharmaceuticals to Underperform from Outperform due to "underwhelming" efficacy data that was presented at AACR earlier in April. The analyst lowered his market penetration assumptions in two indications to a peak of 20% in renal cell focus, 15% in 2L non-small cell lung cancer given less impactful data than he was expecting. He remains at a 35% probability of success for both indications.
08/02/17
WEDB
08/02/17
INITIATION
Target $26
WEDB
Outperform
Corvus Pharmaceuticals initiated with an Outperform at Wedbush
Wedbush initiated Corvus Pharmaceuticals with an Outperform and a $26 price target.
08/03/17
WEDB
08/03/17
INITIATION
WEDB
Outperform
Corvus Pharmaceuticals initiated on positive strategy at Wedbush
As noted earlier, Wedbush started coverage of Corvus with a $26 price target and an Outperform rating. Analyst Robert Driscoll thinks that the company's "strategy of focusing on the majority of patients who do not initially...benefit from current immune checkpoint approaches will pay off as clinical data matures." The analyst says that the company's lead drug, CPI-444, "has demonstrated anti-tumor activity," and he thinks a second drug, CPI-444, is "differentiated" on tolerability.
04/05/17
COWN
04/05/17
NO CHANGE
COWN
Outperform
Corvus Pharmaceuticals risk/reward favorable heading into ASCO, says Cowen
Cowen analyst Boris Peaker noted Corvus Pharmaceuticals shares have sold off 50% following the release of initial Phase 1/1b data for its drug to treat advanced solid tumors. The analyst said RCC and NSLC cohort data show mono activity and combo synergy, which will provide a path forward. He now sees a favorable risk/reward heading into the ASCO meeting in June. Peaker reiterated his Outperform rating on Corvus Pharmaceuticals shares.
MTEM Molecular Templates
$5.50

4.96 (918.52%)

08/03/17
LTCO
08/03/17
INITIATION
Target $10
LTCO
Buy
Molecular Templates initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Kevin DeGeeter started Molecular Templates with a Buy rating and $10 price target. The analyst believes the company's Engineered Toxin Bodies platform offers a differentiated mechanism.
PVH PVH Corp.
$120.51

0.78 (0.65%)

05/30/17
FBCO
05/30/17
UPGRADE
Target $136
FBCO
Outperform
PVH Corp. upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Christian Buss upgraded PVH Corp. to Outperform and raised his price target for the shares to $136 from $114. The company's international opportunity could add an incremental $2.1B in revenue and $3.00 in earnings per share, Buss tells investors in a research note. He sees international markets as de-risking softness in North America.
06/26/17
UBSW
06/26/17
NO CHANGE
Target $128
UBSW
Buy
PVH Corp. likely to raise guidance, says UBS
UBS analyst Michael Binetti met with PVH management and came away confident the company has the most visible path to double digit earnings growth in his coverage universe. He said trends are running ahead of plan, adding that he expects the company to raise guidance. He expects PVH to continue rolling up licenses and thinks the company is getting serious about acquiring another major brand. Binetti reiterated his Buy rating and raised his price target to $128 from $120 on PVH shares.
07/17/17
BUCK
07/17/17
INITIATION
Target $127
BUCK
Buy
PVH Corp. assumed with a Buy at Buckingham
Buckingham analyst Eric Tracy assumed coverage of PVH Corp. with a Buy rating and $127 price target.
08/03/17
BOFA
08/03/17
INITIATION
Target $146
BOFA
Buy
PVH Corp. reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Heather Balsky resumed coverage on PVH Corp with a Buy and a $146 price target given strong international growth, further upside in North America if retail improves, and positive earnings revisions.
ESQ Esquire Financial
$14.80

-0.09 (-0.60%)

08/03/17
SDLR
08/03/17
INITIATION
Target $17
SDLR
Buy
Esquire Financial initiated with a Buy at Sandler O'Neill
Sandler O'Neill analyst Nicholas Cucharale initiated Esquire Financial with a Buy and a $17 price target saying it is poised for a ramp in profitability.

TODAY'S FREE FLY STORIES

INFY

Infosys

$14.79

-1.14 (-7.16%)

04:04
08/21/17
08/21
04:04
08/21/17
04:04
Downgrade
Infosys rating change  »

Infosys downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 06

    Sep

CPN

Calpine

$14.92

1.42 (10.52%)

04:02
08/21/17
08/21
04:02
08/21/17
04:02
Downgrade
Calpine rating change  »

Calpine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$105.92

7.6 (7.73%)

04:02
08/21/17
08/21
04:02
08/21/17
04:02
Upgrade
Estee Lauder rating change  »

Estee Lauder upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOC

Physicians Realty Trust

$17.94

-0.24 (-1.32%)

04:01
08/21/17
08/21
04:01
08/21/17
04:01
Upgrade
Physicians Realty Trust rating change  »

Physicians Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBMD

Howard Bancorp

$18.05

0.65 (3.74%)

03:58
08/21/17
08/21
03:58
08/21/17
03:58
Upgrade
Howard Bancorp rating change  »

Howard Bancorp upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

SNA

Snap-On

$147.96

-0.86 (-0.58%)

03:56
08/21/17
08/21
03:56
08/21/17
03:56
Downgrade
Snap-On rating change  »

Snap-On downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 06

    Sep

E

Eni SpA

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Eni SpA rating change  »

Eni SpA downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STO

Statoil

$18.41

0.31 (1.71%)

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Statoil rating change  »

Statoil downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REPYY

Repsol

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Repsol rating change  »

Repsol downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$50.49

0.61 (1.22%)

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Total rating change  »

Total downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSIQ

Canadian Solar

$16.63

0.23 (1.40%)

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Canadian Solar rating change  »

Canadian Solar downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

03:43
08/21/17
08/21
03:43
08/21/17
03:43
Upgrade
Advance Auto Parts rating change  »

Advance Auto Parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOME

At Home Group

$22.53

-0.22 (-0.97%)

03:40
08/21/17
08/21
03:40
08/21/17
03:40
Initiation
At Home Group initiated  »

At Home Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWW

Grainger

$161.39

-3.21 (-1.95%)

03:40
08/21/17
08/21
03:40
08/21/17
03:40
Initiation
Grainger initiated  »

Grainger reinstated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 24

    Jan

NKE

Nike

$54.95

-2.51 (-4.37%)

03:40
08/21/17
08/21
03:40
08/21/17
03:40
Downgrade
Nike rating change  »

Nike downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

03:40
08/21/17
08/21
03:40
08/21/17
03:40
General news
FX Action: USD-CAD has settled near 1.2600 »

FX Action: USD-CAD has…

03:05
08/21/17
08/21
03:05
08/21/17
03:05
General news
FX Update: The dollar majors traded without drama »

FX Update: The dollar…

WUBA

58.com

$53.26

-0.23 (-0.43%)

20:25
08/20/17
08/20
20:25
08/20/17
20:25
Earnings
Notable company reporting before Monday's open »

The notable company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

WUBA

58.com

$53.26

-0.23 (-0.43%)

20:16
08/20/17
08/20
20:16
08/20/17
20:16
Earnings
Breaking Earnings news story on 58.com »

58.com sees Q3 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

WUBA

58.com

$53.26

-0.23 (-0.43%)

20:11
08/20/17
08/20
20:11
08/20/17
20:11
Earnings
58.com reports Q2 EPS 55c, consensus 20c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

SBUX

Starbucks

$52.70

-0.34 (-0.64%)

, LMT

Lockheed Martin

$299.20

-2.22 (-0.74%)

20:02
08/20/17
08/20
20:02
08/20/17
20:02
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

SBUX

Starbucks

$52.70

-0.34 (-0.64%)

LMT

Lockheed Martin

$299.20

-2.22 (-0.74%)

GDI

Gardner Denver

$21.97

-0.03 (-0.14%)

CAH

Cardinal Health

$64.38

-0.78 (-1.20%)

PDCO

Patterson Companies

$36.45

-0.31 (-0.84%)

RMD

ResMed

$73.07

0.28 (0.38%)

ABC

AmerisourceBergen

$78.60

-1.34 (-1.68%)

UNH

UnitedHealth

$190.82

-1.88 (-0.98%)

AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

MSI

Motorola Solutions

$87.37

0.24 (0.28%)

LGF.A

Lionsgate

$28.41

0.37 (1.32%)

BGS

B&G Foods

$31.40

-0.3 (-0.95%)

MDLZ

Mondelez

$42.94

-0.47 (-1.08%)

SRE

Sempra Energy

$116.55

0.76 (0.66%)

BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 29

    Aug

  • 06

    Sep

  • 11

    Sep

  • 14

    Sep

  • 18

    Sep

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 27

    Sep

  • 29

    Sep

  • 02

    Nov

  • 25

    Jan

SRE

Sempra Energy

$116.55

0.76 (0.66%)

, BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

18:47
08/20/17
08/20
18:47
08/20/17
18:47
Periodicals
Sempra Energy near deal to acquire Oncor Electric, Bloomberg reports »

Sempra Energy (SRE) is…

SRE

Sempra Energy

$116.55

0.76 (0.66%)

BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

TWX

Time Warner

$101.19

-0.42 (-0.41%)

, CMCSA

Comcast

$40.52

0.25 (0.62%)

18:34
08/20/17
08/20
18:34
08/20/17
18:34
Hot Stocks
Box Office Battle: 'Hitman's Bodyguard' wins weekend with $21.6M »

Lionsgate' (LGF.A)…

TWX

Time Warner

$101.19

-0.42 (-0.41%)

CMCSA

Comcast

$40.52

0.25 (0.62%)

CMCSK

Comcast

SNE

Sony

$38.77

-0.23 (-0.59%)

FOX

21st Century Fox

$26.79

-0.1 (-0.37%)

FOXA

21st Century Fox

$27.26

-0.09 (-0.33%)

LGF.A

Lionsgate

$28.41

0.37 (1.32%)

DIS

Disney

$100.70

-0.68 (-0.67%)

VIAB

Viacom

$28.59

-0.62 (-2.12%)

VIA

Viacom

$38.80

-3.6 (-8.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 27

    Sep

  • 29

    Sep

GME

GameStop

$21.22

0.12 (0.57%)

, MSFT

Microsoft

$72.49

0.09 (0.12%)

17:08
08/20/17
08/20
17:08
08/20/17
17:08
Hot Stocks
GameStop kicks off nationwide pre-orders for Microsoft Xbox One X »

GameStop (GME) is…

GME

GameStop

$21.22

0.12 (0.57%)

MSFT

Microsoft

$72.49

0.09 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

GS

Goldman Sachs

$222.15

0.73 (0.33%)

16:48
08/20/17
08/20
16:48
08/20/17
16:48
Periodicals
Goldman Sachs receives approval to trade equities in Saudi Arabia, Reuters says »

Goldman Sachs has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.